Anaphylaxis News and Research

RSS

Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.

Milk allergy - is it overdiagnosed?

A new review published in the journal JAMA Pediatrics in April 2020 raises the concern that there may be a significant overdiagnosis of cow's milk allergy in babies and young children, stemming from the use of current medical recommendations.

13 Apr 2020

Milk allergy guidelines may be linked to overdiagnosis in babies and children

Current medical guidelines for diagnosing cow's milk allergy in babies and young children may be linked to overdiagnosis of the condition.

13 Apr 2020

Transferring knowledge, not anxiety, can help food-allergic children cope with their fears

A new article in Annals of Allergy, Asthma and Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology discusses the difficulties faced by parents of children with food allergies in not transferring their own anxieties to their children.

25 Feb 2020

Brisbane’s grass pollen season the worst on record, says QUT professor

Brisbane’s grass pollen levels over the past two months have been up to four times higher than levels recorded anywhere in Australia since comparative records have been kept, QUT’s Professor Janet Davies told a federal parliamentary inquiry this week.

20 Feb 2020

FDA approves first oral immunotherapy treatment for peanut allergy in children, teens

The University of Chicago Medicine was part of a landmark clinical trial that led to approval by the U.S. Food and Drug Administration of the first oral immunotherapy treatment for peanut allergy in children and teens.

13 Feb 2020

FDA-approved OIT product marks major milestone in management of peanut allergies

In February 2020, the U.S. Food and Drug Administration (FDA) approved Palforzia, the first peanut powder product designed to help reduce the risk of severe peanut-induced allergic reactions through desensitization over time.

4 Feb 2020

People with peanut allergies avoid tree nuts despite being non-allergic to them

A new study reveals that 4 in 10 people who have peanut allergies choose not to consume tree nuts, despite not having allergies to these nuts. The study titled, “Real world tree nut consumption in peanut-allergic individuals,” was published in Annals of Allergy, Asthma and Immunology in the latest issue. The journal is the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

19 Dec 2019

People allergic to peanuts can safely eat tree nuts, but nearly 40% choose avoidance

A new article in Annals of Allergy, Asthma and Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology shows most people allergic to peanuts can safely eat tree nuts.

18 Dec 2019

Researchers identify novel genes associated with severity of peanut allergy

Researchers at the Icahn School of Medicine at Mount Sinai have identified novel genes associated with the severity of peanut allergy, as well as ways in which these genes interact with other genes during allergic reactions.

14 Dec 2019

Breakthrough research develops novel vaccine poised to cure peanut allergies

Peanut allergies could become a thing of the past as breakthrough research from the University of South Australia develops a radically novel vaccination that's poised to cure the potentially life threatening condition.

6 Dec 2019

Children with food allergies are seen sooner when treated by community pediatricians

Children with food allergies are seen 10 months sooner and have fewer allergic reactions when treated by a pediatrician in their own community, a new study shows.

4 Dec 2019

Looking for the source: new routes for allergy treatment

A new multinational study has reported a very full account of the B lymphocytes that produce group E antibodies, also called IgE (Immunoglobulin E), that are behind allergic reactions, which are common in up to a third of the world’s population.

26 Nov 2019

Study about cells producing group E antibodies would help fight against allergies

Researchers of Sechenov University together with their colleagues from Russia and Austria summarized everything known about cells producing group E antibodies

25 Nov 2019

New treatment stops peanut allergy for 6 weeks with single dose

A small study published in the journal JCI Insight on November 14, 2019, suggests that antibody treatment could help people with severe allergy to peanuts eat a small amount of peanut-containing food just two weeks later, without any ill effects. This seems to show that this is a safe, fast and effective treatment for food allergy.

14 Nov 2019

New information on benefits of oral food challenges when diagnosing food allergies

Oral food challenges (OFCs) are the gold standard for allergists when diagnosing a food allergy. The person being tested is given a very small dose of the food by mouth under the supervision of a board-certified allergist to test for a severe reaction.

8 Nov 2019

UGA researcher working to correct penicillin allergy misconception

More than 30 million people in the United States wrongly believe they are allergic to penicillin - resulting in millions of dollars in added health care costs, adverse side effects from the use of more powerful antibiotics and a risk in the rise of dangerous antibiotic resistant infections.

29 Oct 2019

Heavier babies more likely to develop childhood allergies

A new study shows that babies who weigh more at any gestational age have a higher risk of later developing food allergies or eczema in childhood. However, there was no increase in the risk of hay fever. The paper published in the Journal of Allergy and Clinical Immunology found that the risk of food allergy went up by 44% and of eczema by 17% for each kilogram of added weight. On the other hand, restricted growth in the womb appears to be protective.

15 Oct 2019

Peripherally inserted central catheters associated with serious allergic reactions in patients

Peripherally inserted central catheters (PICCs) that use a magnetized tip to guide insertion were associated with serious allergic reactions in patients, according to a study published today in Infection Control & Hospital Epidemiology, the journal for the Society for Healthcare Epidemiology of America. Severe adverse reactions occurred in patients within minutes of PICC insertion.

8 Oct 2019

New 'Idiopathic Anaphylaxis Yardstick' offers guidance for diagnosis and treatment

Many people in danger of the severe allergic reaction known as anaphylaxis understand exactly what they need to avoid to stay safe.

18 Sep 2019

Research reveals potential target for therapies to prevent severe allergic reactions

Allergies can be life-threatening when they cause anaphylaxis, an extreme reaction with constriction of the airways and a sudden drop in blood pressure.

2 Aug 2019